Checkmate Pharmaceuticals, Inc. operates as a biotechnology company. The Company discovers and develops novel approaches for cancer immunotherapy such as immuno-oncology. Checkmate Pharmaceuticals serves patients worldwide. Show more

Location: | Website: checkmatepharma.com | Industry: | Sector:

Market Cap

0.00

52 Wk Range

$N/A - $N/A

Previous Close

$10.50

Open

$10.50

Volume

N/A

Day Range

$10.50 - $10.50

Enterprise Value

0.00

Cash

0.00

Avg Qtr Burn

N/A

Insider Ownership

0.00%

Institutional Own.

0.00%

Qtr Updated

06/30/24

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Vidutolimod (CMP-001) Details Head and neck cancer, Cancer	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Vidutolimod (CMP-001) Details Melanoma, Cancer	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Vidutolimod (CMP-001) Details Cancer, Melanoma	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Vidutolimod (CMP-001) Details Cancer, Cutaneous squamous cell carcinoma	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.